TR200003377T2 - Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol - Google Patents

Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol

Info

Publication number
TR200003377T2
TR200003377T2 TR2000/03377T TR200003377T TR200003377T2 TR 200003377 T2 TR200003377 T2 TR 200003377T2 TR 2000/03377 T TR2000/03377 T TR 2000/03377T TR 200003377 T TR200003377 T TR 200003377T TR 200003377 T2 TR200003377 T2 TR 200003377T2
Authority
TR
Turkey
Prior art keywords
aminoethoxy
estrogens
benzyl
phenyl
indole
Prior art date
Application number
TR2000/03377T
Other languages
English (en)
Inventor
Harrison Pickar James
Samuel Komm Barry
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200003377(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of TR200003377T2 publication Critical patent/TR200003377T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Abstract

Bu bulus, bir veya daha fazla estrojen ve 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol bilesiklerini içeren, estrojenik ajanlar olarak yararli yeni formülasyonlar ve farmakolojik kompozisyonlar ile bilesikleri kullanan tedavi yöntemlerine iliskin olup burada (I) ve (II) genel yapilari söz konusudur.
TR2000/03377T 1998-05-15 1999-05-11 Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol TR200003377T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
TR200003377T2 true TR200003377T2 (tr) 2001-03-21

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03377T TR200003377T2 (tr) 1998-05-15 1999-05-11 Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol

Country Status (42)

Country Link
EP (1) EP1076558B1 (tr)
JP (3) JP2002515431A (tr)
KR (1) KR100620772B1 (tr)
CN (1) CN1230163C (tr)
AP (1) AP1424A (tr)
AR (1) AR020074A1 (tr)
AT (1) ATE245026T1 (tr)
AU (1) AU760378B2 (tr)
BE (1) BE2015C026I2 (tr)
BG (1) BG64783B1 (tr)
BR (1) BR9911040A (tr)
CA (1) CA2329530A1 (tr)
CU (1) CU23241B7 (tr)
CY (1) CY2015020I1 (tr)
CZ (1) CZ299334B6 (tr)
DE (1) DE69909616T2 (tr)
DK (1) DK1076558T3 (tr)
EA (1) EA005932B1 (tr)
EE (1) EE04262B1 (tr)
ES (1) ES2203131T3 (tr)
FR (1) FR15C0035I2 (tr)
GE (1) GEP20033079B (tr)
HK (1) HK1031691A1 (tr)
HR (1) HRP20000778B1 (tr)
HU (2) HU226587B1 (tr)
ID (1) ID26890A (tr)
IL (1) IL139130A (tr)
IN (1) IN192220B (tr)
LT (1) LTC1076558I2 (tr)
LU (1) LU92699I2 (tr)
NO (2) NO328129B1 (tr)
NZ (1) NZ508200A (tr)
OA (1) OA11552A (tr)
PL (1) PL194750B1 (tr)
PT (1) PT1076558E (tr)
SI (1) SI1076558T1 (tr)
SK (1) SK284666B6 (tr)
TR (1) TR200003377T2 (tr)
TW (1) TW565554B (tr)
UA (1) UA66861C2 (tr)
WO (1) WO1999059581A1 (tr)
ZA (1) ZA200006959B (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
WO2001001969A2 (en) 1999-07-06 2001-01-11 Endorecherche, Inc. Methods of treating and/or suppressing weight gain
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
AU2001273125A1 (en) * 2000-07-06 2002-01-21 American Home Products Corporation Combinations of bisphosphonates, estrogenic agents and optionally estrogens
CA2414060A1 (en) * 2000-07-06 2002-01-17 Wyeth Combinations of statins, estrogenic agents and optionally estrogens
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
CZ2004118A3 (cs) 2001-07-31 2004-09-15 Pfizer Products Inc. Farmaceutický prostředek, kit a způsoby zahrnující kombinaci činidla estrogenový agonist/antagonist, estrogenu a progestinu
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
DK2276732T3 (en) 2008-04-16 2015-08-17 Karobio Ab Novel østrogenreceptorligander
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
AU2018386201A1 (en) * 2017-12-15 2020-07-30 Bristol-Myers Squibb Company Substituted indole ether compounds
IT201800006562A1 (it) 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
JP2023517393A (ja) * 2020-03-17 2023-04-25 メッドシャイン ディスカバリー インコーポレイテッド タンパク質分解調整剤およびその使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
EP0639567A1 (en) * 1992-05-08 1995-02-22 Otsuka Pharmaceutical Factory, Inc. Indole derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
ES2162198T3 (es) * 1996-04-19 2001-12-16 American Home Prod Agentes estrogenos.
CA2259598A1 (en) * 1996-07-09 1998-01-15 Smithkline Beecham S.P.A. Indole derivatives for the treatment of osteoporosis
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
KR100669836B1 (ko) * 1997-10-15 2007-01-18 와이어쓰 신규한 아릴옥시-알킬-디알킬아민 및 이의 제조 방법
WO1999021557A1 (en) * 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.

Also Published As

Publication number Publication date
NO20005770L (no) 2001-01-12
AR020074A1 (es) 2002-04-10
CA2329530A1 (en) 1999-11-25
KR20010043641A (ko) 2001-05-25
WO1999059581A1 (en) 1999-11-25
HRP20000778A2 (en) 2001-06-30
ID26890A (id) 2001-02-15
DE69909616T2 (de) 2004-06-17
EP1076558A1 (en) 2001-02-21
IL139130A0 (en) 2001-11-25
DE69909616D1 (de) 2003-08-21
GEP20033079B (en) 2003-10-27
PL345268A1 (en) 2001-12-03
CY2015020I1 (el) 2020-05-29
CZ299334B6 (cs) 2008-06-25
FR15C0035I1 (tr) 2015-06-26
EE200000652A (et) 2002-04-15
EA005932B1 (ru) 2005-08-25
HUS1500023I1 (hu) 2017-03-28
TW565554B (en) 2003-12-11
IN192220B (tr) 2004-03-20
AP1424A (en) 2005-06-06
BR9911040A (pt) 2001-02-13
ZA200006959B (en) 2001-11-27
SK17202000A3 (sk) 2001-07-10
BG64783B1 (bg) 2006-04-28
BE2015C026I2 (en) 2018-08-24
CU23241B7 (es) 2007-10-17
AU3894499A (en) 1999-12-06
NO328129B1 (no) 2009-12-14
EA200001193A1 (ru) 2001-12-24
NO2015015I2 (no) 2015-06-02
PL194750B1 (pl) 2007-06-29
AU760378B2 (en) 2003-05-15
CN1326347A (zh) 2001-12-12
SI1076558T1 (en) 2003-10-31
JP2009019042A (ja) 2009-01-29
CN1230163C (zh) 2005-12-07
EE04262B1 (et) 2004-04-15
ATE245026T1 (de) 2003-08-15
LU92699I2 (fr) 2015-06-24
NO2015015I1 (no) 2015-06-02
FR15C0035I2 (fr) 2015-08-28
AP2000001970A0 (en) 2000-12-31
JP5872624B2 (ja) 2016-03-01
IL139130A (en) 2005-11-20
NZ508200A (en) 2003-09-26
UA66861C2 (uk) 2004-06-15
HU226587B1 (en) 2009-04-28
PT1076558E (pt) 2003-11-28
EP1076558B1 (en) 2003-07-16
HRP20000778B1 (en) 2004-10-31
HUP0103096A2 (hu) 2002-05-29
JP5607871B2 (ja) 2014-10-15
KR100620772B1 (ko) 2006-09-13
DK1076558T3 (da) 2003-11-03
SK284666B6 (sk) 2005-08-04
HUP0103096A3 (en) 2002-11-28
JP2002515431A (ja) 2002-05-28
JP2014159472A (ja) 2014-09-04
BG104930A (en) 2001-07-31
CZ20004254A3 (cs) 2001-12-12
LTC1076558I2 (lt) 2016-11-10
NO20005770D0 (no) 2000-11-14
OA11552A (en) 2004-06-07
ES2203131T3 (es) 2004-04-01
HK1031691A1 (en) 2001-06-22

Similar Documents

Publication Publication Date Title
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
TR200102800T2 (tr) Yeni bileşikler.
MX9702865A (es) Agentes estrogenicos.
PT998460E (pt) Novos derivados de tetrazole
TR200101814T2 (tr) Sulu reaktif dolgu bileşimleri (II)
DE69809726T2 (de) Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
BR9806752A (pt) Ftalazinonas.
TR199801679T2 (tr) Osteoporoz için birlestirme terapisi.
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
SE9702773D0 (sv) Novel compounds
TR200002896T2 (tr) Kalsilitik Bileşimler
TR200102041T2 (tr) Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
DE60117594D1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
DK1204659T3 (da) Serotonerge benzofuraner
ES2171697T3 (es) Antagonistas del receptor de endotelina.
DK0977871T3 (da) Neurotrypsin
TR200101030T2 (tr) İnsanlara özgü NK3 reseptörlerinin seçici antagonistleri olarak üreidopiperidin türevleri
ATE339415T1 (de) Benzocarbazol und indenoindole derivate als östrogene agentien
TR199701011A2 (tr) 1-karba-(detia)-sefalosforin türevleri.
ID27964A (id) Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya